The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
The role of STATs in transcriptional control and their impact on cellular function
Abstract
The STAT proteins (Signal Transducers and Activators of Transcription), were identified in the last decade as transcription factors which were critical in mediating virtually all cytokine driven signaling. These proteins are latent in the cytoplasm and become activated through tyrosine phosphorylation which typically occurs through cytokine receptor associated kinases (JAKs) or growth factor receptor tyrosine kinases. Recently a number of non-receptor tyrosine kinases (for example src and abl) have been found to cause STAT phosphorylation. Phosphorylated STATs form homo- or hetero-dimers, enter the nucleus and working coordinately with other transcriptional co-activators or transcription factors lead to increased transcriptional initiation. In normal cells and in animals, ligand dependent activation of the STATs is a transient process, lasting for several minutes to several hours. In contrast, in many cancerous cell lines and tumors, where growth factor dysregulation is frequently at the heart of cellular transformation, the STAT proteins (in particular Stats 1, 3 and 5) are persistently tyrosine phosphorylated or activated. The importance of STAT activation to growth control in experiments using anti-sense molecules or dominant negative STAT protein encoding constructs performed in cell lines or studies in animals lacking specific STATs strongly indicate that STATs play an important role in controlling cell cycle progression and apoptosis. Stat1 plays an important role in growth arrest, in promoting apoptosis and is implicated as a tumor suppressor; while Stats 3 and 5 are involved in promoting cell cycle progression and cellular transformation and preventing apoptosis. Many questions remain including: (1) a better understanding of how the STAT proteins through association with other factors increase transcription initiation; (2) a more complete definition of the sets of genes which are activated by different STATs and (3) how these sets of activated genes differ as a function of cell type. Finally, in the context of many cancers, where STATs are frequently persistently activated, an understanding of the mechanisms leading to their constitutive activation and defining the potential importance of persistent STAT activation in human tumorigenesis remains. Oncogene (2000).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IL-6 is also a key factor in inflammation, autoimmunity and cancer, with its effect mainly exerted through the IL-6–signal transducer and activator of transcription 3 (STAT3) pathway (18–26, 61–65).”
From IL-6 in inflammation, autoimmunity and cancer (2021) · cites this paper as [61]
In the citing paper
“HCV core protein interacts with the signal transducer and activator of transcription 3 (STAT3) protein36, a transcription factor involved in mediating cytokine signalling37.”
From Inflammation and cancer (2002) · cites this paper as [37]
Citations
Cites
Darnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080
Darnell, J. E. (1997) · Science · doi:10.1126/science.277.5332.1630 · Cited by 3,979
HOW CELLS RESPOND TO INTERFERONS
Stark, G. R., Kerr, I. M., Williams, B. R. G., Silverman, R. H., & Schreiber, R. D. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.227 · Cited by 3,932
Virus interference. I. the interferon
Isaacs, A., & Lindenmann, J. (1957) · Proceedings of the Royal Society of London. Series B - Biological Sciences · doi:10.1098/rspb.1957.0048 · Cited by 3,451
Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C., & Darnell, J. E. (1999) · Cell · doi:10.1016/s0092-8674(00)81959-5 · Cited by 2,790
Self-citationWen, Z., Zhong, Z., & Darnell, J. E. (1995) · Cell · doi:10.1016/0092-8674(95)90311-9 · Cited by 1,974
Meraz, M. A., White, J. M., Sheehan, K. C. F., Bach, E. A., Rodig, S. J., Dighe, A. S., Kaplan, D. H., Riley, J. K., Greenlund, A. C., Campbell, D., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81288-x · Cited by 1,656
Targeted Disruption of the Mouse Stat1 Gene Results in Compromised Innate Immunity to Viral Disease
Durbin, J. E., Hackenmiller, R., Simon, M. C., & Levy, D. E. (1996) · Cell · doi:10.1016/s0092-8674(00)81289-1 · Cited by 1,539
A Matter of Life and Cell Death
Evan, G. I., & Littlewood, T. D. (1998) · Science · doi:10.1126/science.281.5381.1317 · Cited by 1,528
Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice
Kaplan, D. H., Shankaran, V., Dighe, A. S., Stockert, E., Aguet, M., Old, L. J., & Schreiber, R. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7556 · Cited by 1,465
Cited by
Sorted by citations
Items 301–400 of 1,000
Masciocchi, D., Gelain, A., Villa, S., Meneghetti, F., & Barlocco, D. (2011) · Future Medicinal Chemistry · doi:10.4155/fmc.11.22 · Cited by 80
Liang, Q., Xiong, H., Zhao, Z., Jia, D., Li, W., Qin, H., Deng, J., Gao, L., Zhang, H., & Gao, G. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.08.011 · Cited by 78
Serrano, L., Rodríguez‐Calvo, R., Kochairi, I. E., Palomer, X., Michalik, L., Wahli, W., & Vázquez‐Carrera, M. (2011) · Diabetes · doi:10.2337/db10-0704 · Cited by 80
Pei, T., Meng, Q., Han, J., Sun, H., Li, L., Song, R., Sun, B., Pan, S., Liang, D., & Liu, L. (2016) · Oncotarget · doi:10.18632/oncotarget.9782 · Cited by 80
Intramitochondrial Disulfide Polymerization Controls Cancer Cell Fate
Kim, S., Jana, B., Go, E. M., Lee, J. E., Jin, S., An, E., Hwang, J., Sim, Y., Son, S., Kim, D., et al. (2021) · ACS Nano · doi:10.1021/acsnano.1c04015 · Cited by 78
Chua, L. S. (2014) · Phytotherapy Research · doi:10.1002/ptr.5193 · Cited by 77
Gartsbein, M., Alt, A., Hashimoto, K., Nakajima, K., Kuroki, T., & Tennenbaum, T. (2006) · Journal of Cell Science · doi:10.1242/jcs.02744 · Cited by 81
MUC1 is a downstream target of STAT3 and regulates lung cancer cell survival and invasion
Haura (2009) · International Journal of Oncology · doi:10.3892/ijo_00000345 · Cited by 77
Tao, J., Zhi, X., Zhang, X., Fu, M., Huang, H., Fan, Y. J., Guan, W., & Zou, C. (2015) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-015-0253-3 · Cited by 77
Parakh, S., Ernst, M., & Poh, A. R. (2021) · Cancers · doi:10.3390/cancers13246228 · Cited by 77
Nuclear Translocation of Insulin Receptor Substrate-1 by Oncogenes And Igf-I
Tu, X., Batta, P., Innocent, N., di Prisco, M., Casaburi, I., Belletti, B., & Baserga, R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208001200 · Cited by 76
Ryu, K., Choy, E., Cao, Y., Susa, M., Hornicek, F. J., Mankin, H. J., & Duan, Z. (2010) · Journal of Orthopaedic Research® · doi:10.1002/jor.21088 · Cited by 75
Terui, K., Enosawa, S., Haga, S., Zhang, H. Q., Kuroda, H., Kouchi, K., Matsunaga, T., Yoshida, H., Engelhardt, J. F., Irani, K., et al. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.08.019 · Cited by 76
Nkansah, E., Shah, R., Collie, G. W., Parkinson, G. N., Palmer, J. M., Rahman, K. M., Bui, T. T. T., Drake, A. F., Husby, J., Neidle, S., et al. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.01.065 · Cited by 79
Leelamine Mediates Cancer Cell Death through Inhibition of Intracellular Cholesterol Transport
Kuzu, O. F., Gowda, R., Sharma, A. K., & Robertson, G. P. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0868 · Cited by 80
Inflammation and lung carcinogenesis: applying findings in prevention and treatment
Peebles, K. A., Lee, J. M., Mao, J. T., Hazra, S., Reckamp, K. L., Krysan, K., Dohadwala, M., Heinrich, E. L., Walser, T. C., Cui, X., et al. (2007) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.7.10.1405 · Cited by 77
Stat3-siRNA induces Fas-mediated apoptosis in vitro and in vivo in breast cancer
Rao (2009) · International Journal of Oncology · doi:10.3892/ijo_00000249 · Cited by 75
Cai, G., Yu, W., Song, D., Zhang, W., Guo, J., Zhu, J., Ren, Y., & Kong, L. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.04.024 · Cited by 76
Ren, Z., Ahn, J. H., Liu, H., Tsai, Y., Bhanu, N. V., Koss, B. S., Allison, D. F., Ma, A., Storey, A. J., Wang, P., et al. (2019) · Blood · doi:10.1182/blood.2019000578 · Cited by 76
Xiong, H., Su, W., Liang, Q., Zhang, Z., Chen, H., Du, W., Chen, Y., & Fang, J. (2009) · Laboratory Investigation · doi:10.1038/labinvest.2009.11 · Cited by 74
McPherson, C. A., Aoyama, M., & Harry, G. J. (2010) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.09.003 · Cited by 75
The Src signaling pathway: a potential target in melanoma and other malignancies
Homsi, J., Cubitt, C. L., & DAUD, A. I. (2006) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.1.91 · Cited by 75
Abrogation of constitutive Stat3 activity circumvents cisplatin resistant ovarian cancer
Ji, T., Gong, D., Han, Z., Xiao, W., Yan, Y., Ye, F., Ding, W., Wang, J., Xia, X., Li, F., et al. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.08.022 · Cited by 74
Stat3 enhances transactivation of steroid hormone receptors
Miguel, F. D., Lee, S. O., Oñate, S. A., & Gao, A. C. (2003) · Nuclear Receptor · doi:10.1186/1478-1336-1-3 · Cited by 74
Gwack, Y., Hwang, S., Lim, C., Won, Y. S., Lee, C. H., & Choe, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108289200 · Cited by 74
Current perspectives of molecular pathways involved in chronic inflammation-mediated breast cancer
Suman, S., Sharma, P. K., Rai, G., Mishra, S., Arora, D., Gupta, P., & Shukla, Y. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.10.133 · Cited by 73
Uncovering the pathogenesis of large granular lymphocytic leukemia—novel STAT3 and STAT5b mutations
Rajala, H. L. M., Porkka, K., Maciejewski, J. P., Loughran, T. P., & Mustjoki, S. M. (2014) · Annals of Medicine · doi:10.3109/07853890.2014.882105 · Cited by 74
Horinaga, M., Okita, H., Nakashima, J., Kanao, K., Sakamoto, M., & Murai, M. (2005) · Urology · doi:10.1016/j.urology.2005.03.066 · Cited by 73
Kasper, S. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20339 · Cited by 73
Rozovski, U., Wu, J. Y., Harris, D., Liu, Z., Li, P., Hazan‐Halevy, I., Ferrajoli, A., Burger, J. A., O'Brien, S. M., Jain, N., et al. (2014) · Blood · doi:10.1182/blood-2013-10-534073 · Cited by 75
STAT3 and suppressor of cytokine signaling 3: potential targets in lung inflammatory responses
Gao, H., & Ward, P. A. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.7.869 · Cited by 75
Hypoxic repression of STAT1 and its downstream genes by a pVHL/HIF-1 target DEC1/STRA13
Ivanov, S. V., Salnikow, K., Ivanova, A. V., Bai, L., & Lerman, M. I. (2006) · Oncogene · doi:10.1038/sj.onc.1209842 · Cited by 73
Matsuda, T., Junicho, A., Yamamoto, T., Kishi, H., Korkmaz, K., Saatcioglu, F., Fuse, H., & Muraguchi, A. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4758 · Cited by 76
Mitochondria targeted fluorogenic theranostic agents for cancer therapy
Singh, H., Sareen, D., George, J. M., Bhardwaj, V., Rha, H., Lee, S. J., Sharma, S., Sharma, A., & Kim, J. S. (2022) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2021.214283 · Cited by 72
Yue, P., Lopez‐Tapia, F., Paladino, D., Li, Y., Chen, C., Namanja, A. T., Hilliard, T. S., Chen, Y., Tius, M. A., & Turkson, J. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3558 · Cited by 72
Liao, J., Xu, T., Zheng, J., Lin, J., Cai, Q., Yu, D., & Peng, J. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2013.1358 · Cited by 72
Akt Modulates STAT3-mediated Gene Expression through a FKHR (FOXO1a)-dependent Mechanism
Kortylewski, M., Feld, F., Krüger, K.-D., Bahrenberg, G., Roth, R. A., Joost, H., Heinrich, P. C., Behrmann, I., & Barthel, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m205403200 · Cited by 73
STAT3 silencing inhibits glioma single cell infiltration and tumor growth
Priester, M., Copanaki, E., Vafaizadeh, V., Hensel, S., Bernreuther, C., Glatzel, M., Seifert, V., Groner, B., Kögel, D., & Weissenberger, J. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not025 · Cited by 75
STAT Signaling in Glioma Cells
Swiatek-Machado, K., & Kaminska, B. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-4719-7_10 · Cited by 74
Barton, B. E., Karras, J. G., Murphy, T. F., Barton, A. B., & Huang, H. F. S. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.11.3.1 · Cited by 72
Mechanisms of Transformation by the BCR/ABL Oncogene
Sattler, M., & Griffin, J. D. (2001) · International Journal of Hematology · doi:10.1007/bf02981952 · Cited by 74
Kim, J. Y., Ahn, J., Kim, J., Choi, M., Jeon, H., Choe, K., Lee, D. Y., Kim, P., & Jon, S. (2018) · ACS Nano · doi:10.1021/acsnano.8b02330 · Cited by 71
Beyond the Gut: The intratumoral microbiome's influence on tumorigenesis and treatment response
Zhang, H., Fu, L., Leiliang, X., Qu, C., Wu, W., Wen, R., Huang, N., He, Q., Cheng, Q., Liu, G., et al. (2024) · 癌症:英文版 · doi:10.1002/cac2.12597 · Cited by 74
Mechanisms of Local Immunoresistance in Glioma
Albesiano, E., Han, J. E., & Lim, M. K. (2009) · Neurosurgery Clinics of North America · doi:10.1016/j.nec.2009.08.008 · Cited by 72
Kim, K.-J., Kwon, S.-H., Yun, J.-H., Jeong, H.-S., Kim, H.-R., Lee, E. H., Ye, S.-K., & Cho, C.-H. (2017) · Oncogene · doi:10.1038/onc.2017.148 · Cited by 70
Kumar, R., Bunn, P. T., Singh, S. S., Ng, S. S., de, M. M., Rivera, F. D. L., Chauhan, S. B., Singh, N., Faleiro, R. J., Edwards, C. L., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.01.099 · Cited by 73
Zuo, H. X., Jin, Y., Wang, Z., Li, M. Y., Zhang, Z. H., Wang, J. Y., Xing, Y., Ri, M., Jin, C. H., Xu, G. H., et al. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.112835 · Cited by 70
Transcription factors in colorectal cancer: molecular mechanism and therapeutic implications
Xu, H., Liu, L., Li, W., Zou, D., Yu, J. Q., Wang, L., & Wong, C. C. (2020) · Oncogene · doi:10.1038/s41388-020-01587-3 · Cited by 70
Matsui, F., & Meldrum, K. K. (2012) · Journal of Surgical Research · doi:10.1016/j.jss.2012.06.050 · Cited by 70
Drosophila Jak/STAT Signaling: Regulation and Relevance in Human Cancer and Metastasis
Trivedi, S., & Starz‐Gaiano, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19124056 · Cited by 72
Nijhuis, E. H. J., Lammers, J. J., Koenderman, L., & Coffer, P. J. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.1.115 · Cited by 70
Das, S., Roth, C., Wasson, L. M., & Vishwanatha, J. K. (2007) · The Prostate · doi:10.1002/pros.20640 · Cited by 69
Punjabi, A. S., Carroll, P. A., Chen, L., & Lagunoff, M. (2006) · Journal of Virology · doi:10.1128/jvi.01769-06 · Cited by 69
Sai, K., Wang, S., Balasubramaniyan, V., Conrad, C. A., Lang, F. F., Aldape, K., Szymański, S., Fokt, I., Dasgupta, A., Madden, T. L., et al. (2012) · Journal of Neuro-Oncology · doi:10.1007/s11060-011-0786-z · Cited by 69
Pomerantz, R. G., & Grandis, J. R. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2004.09.015 · Cited by 70
Metformin improves salivary gland inflammation and hypofunction in murine Sjögren’s syndrome
Kim, J., Kim, S., Park, J., Hwang, S., Choi, J., Jung, K., Ryu, J., Lee, S.-Y., Kwok, S., Cho, M., et al. (2019) · Arthritis Research & Therapy · doi:10.1186/s13075-019-1904-0 · Cited by 69
Kazansky, A. V., Spencer, D. M., & Greenberg, N. M. (2003) · PubMed · Cited by 68
Convergence of Protein Kinase C and JAK-STAT Signaling on Transcription Factor GATA-4
Wang, J., Paradis, P., Aries, A., Komati, H., Lefèbvre, C., Wang, H., & Nemer, M. J. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.22.9829-9844.2005 · Cited by 68
Erk1/2 activation and modulation of STAT3 signaling in oral cancer
Gkouveris, I., Nikitakis, N. G., Karanikou, M., Rassidakis, G. Z., & Sklavounou, A. (2014) · Oncology Reports · doi:10.3892/or.2014.3440 · Cited by 68
Arsenic inhibition of the JAK-STAT pathway
Cheng, H. Y., Li, P., David, M., Smithgall, T. E., Feng, L., & Lieberman, M. W. (2004) · Oncogene · doi:10.1038/sj.onc.1207466 · Cited by 68
Activation of Stat3 by cell confluence reveals negative regulation of Stat3 by cdk2
Steinman, R. A., Wentzel, A. L., Lu, Y., Stehle, C. J., & Grandis, J. R. (2003) · Oncogene · doi:10.1038/sj.onc.1206523 · Cited by 69
Shin, H.-J., Oh, J., Kang, S., Lee, J. H., Shin, M., Hwang, K.-C., Jang, Y., & Chung, J. H. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.12.195 · Cited by 70
Yoon, C. J., Chang, M. S., Kim, D. H., Kim, W. K., Koo, B. K., Yun, S., Kim, S., Kim, Y. S., & Woo, J. H. (2020) · Gastric Cancer · doi:10.1007/s10120-020-01059-3 · Cited by 67
JAK Inhibitors and Modulation of B Cell Immune Responses in Rheumatoid Arthritis
Moura, R. A., & Fonseca, J. E. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2020.607725 · Cited by 67
Sharma, S., Gangenahalli, G. U., Satija, N. K., Pati, S., Afrin, F., Gupta, P., Verma, Y. K., Singh, V. K., & Tripathi, R. P. (2006) · Stem Cells and Development · doi:10.1089/scd.2006.15.755 · Cited by 71
Cytokines and Their STATs in Cutaneous and Visceral Leishmaniasis
Cummings, H., Tuladhar, R., & Satoskar, A. R. (2010) · BioMed Research International · doi:10.1155/2010/294389 · Cited by 67
Onimoe, G., Liu, A., Lin, L., Wei, C., Schwartz, E. B., Bhasin, D. K., Li, C., Fuchs, J. R., Li, P., Houghton, P. J., et al. (2011) · Investigational New Drugs · doi:10.1007/s10637-011-9645-1 · Cited by 67
SD-1029 Inhibits Signal Transducer and Activator of Transcription 3 Nuclear Translocation
Duan, Z., Bradner, J. E., Greenberg, E. F., Levine, R. L., Foster, R., Mahoney, J., & Seiden, M. V. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1330 · Cited by 67
Messina, J. L., Yu, H., Riker, A. I., Münster, P. N., Jove, R., & DAUD, A. I. (2008) · Cancer Control · doi:10.1177/107327480801500302 · Cited by 68
Sun, Q., Lu, N.-N., & Feng, L. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.02.009 · Cited by 67
Marine natural products for multi-targeted cancer treatment: A future insight
Kumar, M. S., & Adki, K. M. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.05.142 · Cited by 67
Molecules targeting the androgen receptor (AR) signaling axis beyond the AR‐Ligand binding domain
Elshan, N. G. R. D., Rettig, M. B., & Jung, M. E. (2018) · Medicinal Research Reviews · doi:10.1002/med.21548 · Cited by 69
STAT3 Regulates ABCA3 Expression and Influences Lamellar Body Formation in Alveolar Type II Cells
Matsuzaki, Y., Besnard, V., Clark, J. C., Xu, Y. J., Wert, S. E., Ikegami, M., & Whitsett, J. A. (2007) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2007-0311oc · Cited by 67
A new era for IFN-α in the treatment of Philadelphia-negative chronic myeloproliferative neoplasms
Hasselbalch, H. C. (2011) · Expert Review of Hematology · doi:10.1586/ehm.11.63 · Cited by 66
Washburn, K. B., & Neary, J. T. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.06.034 · Cited by 68
Sehara, Y., Sawicka, K., Hwang, J.-Y., Latuszek-Barrantes, A., Etgen, A. M., & Zukin, R. S. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.1852-13.2013 · Cited by 66
Hornakova, T., Staerk, J., Royer, Y., Flex, E., Tartaglia, M., Constantinescu, S. N., Knoops, L., & Renauld, J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807531200 · Cited by 66
Lin, L., Benson, D. M., DeAngelis, S., Bakan, C. E., Li, P., Li, C., & Lin, J. (2012) · International Journal of Cancer · doi:10.1002/ijc.26152 · Cited by 66
Jung, S., Shin, D., Kim, H.-N., Jeon, Y. J., Yun, J., Lee, Y.-J., Kang, J. S., Han, D. C., & Kwon, B. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.06.033 · Cited by 66
Cross‐talk between IL‐6 and TGF‐β signaling in hepatoma cells
Yamamoto, T., Matsuda, T., Muraguchi, A., Miyazono, K., & Kawabata, M. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02258-x · Cited by 65
Hawthorne, V. S., Huang, W.-C., Neal, C. L., Tseng, L.-M., Hung, M., & Yu, D. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0316 · Cited by 70
Huang, J., Kaminski, P. M., Edwards, J. G., Yeh, Y. A., Wolin, M. S., Frishman, W. H., Gewitz, M. H., & Mathew, R. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00069.2007 · Cited by 67
Physical and functional interactions between STAT3 and ZIP kinase
Sato, N., Kawai, T., Sugiyama, K., Muromoto, R., Imoto, S., Sekine, Y., Ishida, M., Akira, S., & Matsuda, T. (2005) · International Immunology · doi:10.1093/intimm/dxh331 · Cited by 67
Wang, W., Guo, C., Zhu, P., Lu, J., Li, W., Liu, C., Xie, H., Myatt, L., Chen, Z., & Sun, K. (2015) · Science Signaling · doi:10.1126/scisignal.aac6151 · Cited by 64
Hwang, J. H., Kim, D. W., Suh, J. M., Kim, H., Song, J. H., Hwang, E. S., Park, K. C., Chung, H. K., Kim, J., Lee, T., et al. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0401 · Cited by 64
Xiao, H., Bid, H. K., Jou, D., Wu, X., Yu, W., Li, C., Houghton, P. J., & Lin, J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.616748 · Cited by 64
Zhang, W., Chan, R. J., Chen, H., Yang, Z., He, Y., Zhang, X., Luo, Y., Yin, F., Moh, A., Miller, L., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.020495 · Cited by 63
Ni, Z., Lou, W., Lee, S. O. K., Dhir, R., Miguel, F. D., Grandis, J. R., & Gao, A. C. (2002) · The Journal of Urology · doi:10.1016/s0022-5347(05)65249-4 · Cited by 63
Perspectives Regarding the Intersections between STAT3 and Oxidative Metabolism in Cancer
Chun, K., Jang, J., & Kim, D. (2020) · Cells · doi:10.3390/cells9102202 · Cited by 62
Han, Z., Wang, X., Ma, L., Chen, L., Xiao, M., Huang, L., Cao, Y., Bai, J., Ma, D., Zhou, J., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2314 · Cited by 63
Cytokine signalling via gp130 in gastric cancer
Howlett, M., Menheniott, T. R., Judd, L. M., & Giraud, A. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2009.07.009 · Cited by 65
High IL-21 receptor expression and apoptosis induction by IL-21 in follicular lymphoma
Akamatsu, N., Yamada, Y., Hasegawa, H., Makabe, K., Asano, R., Kumagai, I., Murata, K., Imaizumi, Y., Tsukasaki, K., Tsuruda, K., et al. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.06.001 · Cited by 61
Ryu, K., Susa, M., Choy, E., Cao, Y., Hornicek, F. J., Mankin, H. J., & Duan, Z. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-187 · Cited by 61
Dendritic cells dysfunction in tumour environment
Bennaceur, K., Chapman, J. A., Brikci-Nigassa, L., Sanhadji, K., Touraine, J. L., & Portoukalian, J. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.05.017 · Cited by 62
Zhang, J., Das, S. C., Kotalik, C., Pattnaik, A. K., & Zhang, L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403966200 · Cited by 61
Wang, J. Y., Jiang, M. W., Li, M. Y., Zhang, Z. H., Xing, Y., Ri, M., Jin, C. H., Xu, G. H., Piao, L. X., Jin, H. L., et al. (2021) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2021.108899 · Cited by 61
Holo-Retinol–Binding Protein and Its Receptor STRA6 Drive Oncogenic Transformation
Berry, D. C., Levi, L., & Noy, N. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1052 · Cited by 62
Lee, Y. K., Isham, C. R., Kaufmann, S. H., & Bible, K. C. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0235 · Cited by 62
STAT-1 facilitates the ATM activated checkpoint pathway following DNA damage
Townsend, P. A., Cragg, M. S., Davidson, S. M., McCormick, J., Barry, S. P., Lawrence, K. M., Knight, R. A., Hubank, M. J. F., Chen, P., Latchman, D. S., et al. (2005) · Journal of Cell Science · doi:10.1242/jcs.01728 · Cited by 62
RetractedBasu, A., Meyer, K., Ray, R. B., & Ray, R. (2001) · Virology · doi:10.1006/viro.2001.1100 · Cited by 60
Metadata
- Authors
- Bromberg, J., & Darnell, J. E.
- Affiliations
- Rockefeller University (US)
- ORCID
- Bromberg, Jacqueline
- Venue
- Oncogene
- Published
- 2000-05-25
- Volume
- 19
- Issue
- 21
- Pages
- 2468-2473
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W1977681992
- Cited by
- 1,201
- References
- 66
- Citations by year
- 2026: 10 · 2025: 22 · 2024: 21 · 2023: 24 · 2022: 37 · 2021: 40 · 2020: 46 · 2019: 41 · 2018: 42 · 2017: 51 · 2016: 46 · 2015: 49 · 2014: 59 · 2013: 67 · 2012: 56
- FWCI
- 6.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Keywords
- STAT proteins, transcriptional regulation, cytokine signaling, JAK kinases, tyrosine phosphorylation, STAT1, STAT3, STAT5, cell cycle progression, apoptosis, tumor suppressor, cell transformation, carcinogenesis, transcriptional coactivator
- MeSH terms
- Animals, Cell Division, Cell Transformation, Neoplastic, DNA-Binding Proteins, Gene Expression Regulation, Humans, Milk Proteins, Neoplasms, Structure-Activity Relationship, Transcription, Genetic, Trans-Activators, STAT1 Transcription Factor, STAT3 Transcription Factor, STAT5 Transcription Factor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review